1. The Impact of Circulating Cholesterol Crystals on Vasomotor Function
- Author
-
Gaurav Dhar, Nitesh Gadeela, Michael J. Rich, Ruiping Huang, George S. Abela, Dorothy Pathak, Jack Rubinstein, Umesh Tamhane, and Hazel Ann A Hosein
- Subjects
medicine.medical_specialty ,Endothelium ,business.industry ,Confocal ,Cholesterol crystals ,Vasodilation ,medicine.disease ,Surgery ,Norepinephrine (medication) ,medicine.anatomical_structure ,Internal medicine ,No reflow phenomenon ,Cardiology ,Medicine ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Vasoconstriction ,Acetylcholine ,medicine.drug - Abstract
Objectives The purpose of this study was to determine if cholesterol crystals can injure the endothelial surface by their jagged edges altering vasoreactivity and contributing to no-reflow after intervention. Background After plaque rupture, cholesterol crystals are released into the circulation and flow downstream contacting the arterial wall. Methods Both carotid arteries from 22 rabbits were placed in a dual perfusion chamber and challenged with norepinephrine followed by acetylcholine and nitroprusside. Arterial diameters were measured before and after exposure to cholesterol crystals or microspheres and compared with diameters of normal control arteries. Arteries were examined by light, confocal, atomic force and scanning electron microscopy. Results Pre-exposure mean arterial diameter was 2.33 ± 0.27 mm. With baseline norepinephrine there was vasoconstriction of 0.82 ± 0.19 mm, 0.79 ± 0.18 mm, and 0.83 ± 0.16 mm in lumen diameter in the crystal, microsphere, and control groups, respectively. After cholesterol crystals or microspheres, vasoconstriction was significantly less for cholesterol crystals but not for microspheres (0.71 ± 0.28 mm and 0.81 ± 0.15 mm; p Conclusions Cholesterol crystals damaged the endothelium and reduced vasodilator response, potentially aggravating myocardial ischemia after interventions.
- Published
- 2011
- Full Text
- View/download PDF